Renal Cancer - Results from #4520

Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy April 5, 2018

Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma April 5, 2018

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer April 4, 2018

Clinical Relevance of Gene Copy Number Variation in Metastatic Clear Cell Renal Cell Carcinoma April 4, 2018

Immune-based identification of cancer patients at high risk of progression April 3, 2018

Carboplatin-based Nanomedicine to Enhance the Anticancer Effect in SK-NEP-1 WilmsꞌTumor Cells. April 3, 2018

The Efficacy of Conventionally Fractionated Radiation in the Management of Osseous Metastases from Metastatic Renal Cell Carcinoma April 3, 2018

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study April 3, 2018

Primary Synovial Sarcoma of the Kidney: a Rare Presentation April 2, 2018

Histopathologic analysis of stage pT1b kidney neoplasms for optimal surgical margins of nephron-sparing surgery April 2, 2018

Late duodenal metastasis from renal cell carcinoma with newly developed malignant lymphoma: A case report April 2, 2018

Chromophobe Renal Cell Carcinoma With Retrograde Venous Invasion and Gain of Chromosome 21: Potential Harbingers of Aggressive Clinical Behavior March 30, 2018

βArrestin2 Mediates Renal Cell Carcinoma Tumor Growth. March 30, 2018

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study March 29, 2018

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma March 29, 2018

Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis March 29, 2018

Metastatic Renal Cell Cancer-Systemic Therapy March 28, 2018

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma March 28, 2018

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update March 28, 2018

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma March 27, 2018

Page 227 of 456